Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis
Non- Interventional Study of Tissucol® for Hemostasis in Subjects With Femoral Vascular Anastomosis Undergoing Vascular Reconstruction With PTFE Prosthesis
1 other identifier
observational
60
2 countries
5
Brief Summary
This study investigates if the time to hemostasis can be reduced by application of Tissucol® onto femoral vascular anastomoses with PTFE prostheses compared to standard methods, such as compression with swabs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2003
Shorter than P25 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 8, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedOctober 23, 2006
October 1, 2006
September 8, 2005
October 20, 2006
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (5)
General Hospital (AKH) Salzburg
Salzburg, Salzburg, 5020, Austria
Landeskrankenhaus Innsbruck
Innsbruck, Tyrol, 6020, Austria
Leonberg Hospital, Department of Vascular Surgery
Leonberg, 71229, Germany
University Clinics of Magdeburg, Department of Vascular Surgery
Magdeburg, 39120, Germany
Klinikum Nürnberg Süd, Department of Vascular Surgery
Nuremberg, 90340, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Bürger, MD
University Clinics of Magdeburg, Germany